Introduction
============

Myopia (short-sightedness) is the most common visual disorder worldwide and the greatest risk factor for many severe ophthalmic diseases in older individuals ([@ref-21]). Rapidly increasing prevalence has been reported among young adults in areas of South East Asia ([@ref-79]) since the 1970s, implicating environmental influences such as changing lifestyles and education as key factors in myopia development ([@ref-21]; [@ref-39]; [@ref-56]; [@ref-82]).

Many of the morphological and physiological characteristics seen in clinical myopia are associated with conditions such as macular oedema, age related maculopathy (AMD), retinal detachment, glaucoma and choroidal neovascularisation (CNV) ([@ref-83]; [@ref-105]). In particular, the elongation of the vitreal chamber, ocular volume increase, thinning of the retina and choroid and reduced choroidal blood flow in clinical myopia ([@ref-8]; [@ref-56]; [@ref-57]; [@ref-103]; [@ref-112]) implicate mechanisms associated with impaired transport of fluid from vitreous to choroid as contributors to significantly greater physiological risk of loss of vision and blindness.

Experimental models of myopia came to prominence in the late 70s in monocularly occluded monkeys ([@ref-72]) and chickens ([@ref-99]). In animal models, particularly chicken, form-deprivation (FD) is characterised by rapid ocular growth and development of myopia via dramatic increases in vitreous chamber volume ([@ref-99]), reduced choroidal blood flow and concurrent choroidal and retinal thinning ([@ref-87]; [@ref-88]; [@ref-89]) (and as shown with the MRI photomicrograph in [Fig. 1](#fig-1){ref-type="fig"}), similar to that seen in profound human myopia ([@ref-8]; [@ref-23]; [@ref-56]; [@ref-57]; [@ref-103]; [@ref-112]).

![MRI images of chick eye following 10 days of FDM induction and 3 days recovery.\
(A) Monocular form-deprivation of the right eye (RE) for 10 days demonstrates abnormal ocular growth, excess vitreal volume, and thinned choroid of RE compared to its fellow left eye (LE). (B) 72 h post-occlusion recovery (i.e., 72 h normal visual experience) resulted in vitreous volume decrease and choroidal expansion. Previous studies ([@ref-46]) have shown ∼300% increase in choroidal thickness in RE compared to LE after three days recovery from FD. Note: Images (same magnification) in (B) slightly more dorsal than in (A). Image credit: G Egan.](peerj-06-5048-g001){#fig-1}

Similarity in observations of human and animal models of myopia led to the formulation of the Retinal Ion Driven Efflux (RIDE) model of myopia ([@ref-15]). This theory proposes that acute blur will perturb the rate of exchange of ions and fluid between photoreceptors and the sub-retinal space, concurrently affecting neurotransmission ([@ref-100]), tissue osmoregulation ([@ref-16]) and metabolic pathways across the posterior eye ([@ref-77]). As a consequence, inhibition of normal efflux of fluid across the retina/RPE would result in increases in vitreous volume, axial growth and induce changes in refractive status leading to myopia.

The relevance of the chick model in particular to understanding of human myopia has recently been highlighted by [@ref-74] who first demonstrated that the genes near human GWAS of myopia identified refractive error loci that significantly overlap with the genes differentially expressed in animal transcriptome studies. Furthermore, [@ref-75] also showed that the genes and proteins differentially expressed in chick myopia and hyperopia models overlap significantly with the genes and proteins implicated in the pathogenesis of sight-threatening secondary disorders.

Previous ultrastructural studies of form-deprivation in chick have demonstrated morphological abnormalities in photoreceptor outer segments, retinal pigment epithelium (RPE) nuclei, mitochondria and basal laminae ([@ref-7]; [@ref-45]; [@ref-46]; [@ref-47]) similar to those described elsewhere as characteristic of AMD ([@ref-18]), CNV ([@ref-64]) and glaucoma ([@ref-42]). These morphological changes occur concomitantly with elemental microanalytical evidence of hyperosmotic changes in ion distribution patterns across the retina, RPE and choroid ([@ref-16]; [@ref-32]; [@ref-37]; [@ref-40]; [@ref-45]; [@ref-46]) and reminiscent of physiologically induced hyperosmotic and oxidative stress elsewhere in the brain ([@ref-13]; [@ref-58]; [@ref-97]). Indeed, oxidative stress has been suggested to contribute to the underlying mechanisms involved in profound myopia pathology ([@ref-27]).

Our recent RNA sequencing analysis of the genomic changes associated with early optical induction of myopic and hyperopic refractive errors ([@ref-77]) also suggested that metabolic pathways will be altered in any genomic analysis of environmentally induced change in light driven neurotransmission particularly in the most extreme of form-deprivation (FD).

Over the last decade there have been many large discovery type transcriptome studies examining the genomic basis of environmentally altered eye growth in animal models of refractive error development ([@ref-6]; [@ref-11]; [@ref-33]; [@ref-34]; [@ref-35]; [@ref-52]; [@ref-70]; [@ref-77]; [@ref-80]; [@ref-81]; [@ref-85]; [@ref-93]; [@ref-95]). As with human genome-wide association studies (GWAS), the majority of the identified genes converge into biological pathways such as cell structure, cell--cell communication, neurotransmission, retinoic acid metabolism, ion transport, energy metabolism, immune system and eye development ([@ref-38]; [@ref-41]; [@ref-74]; [@ref-92]; [@ref-98]). However, the large number of genes implicated in both human GWAS and animal transcriptome studies have not offered a coherent explanation for the anatomically derived evidence of mitochondrial and hyperosmotic stress seen across the posterior retina/RPE/choroid of the FDM eye. Thus, the aim of this study was to investigate whether similar gene pathways are also related to the excessive axial growth, ultrastructural and elemental microanalytic changes seen during the induction and recovery from form-deprivation myopia (FDM) in chick.

To test the expected association between the ultrastructural changes and the RIDE model ([@ref-15]) during the induction and recovery from FDM that we have previously examined ([@ref-16]; [@ref-46]), we have reanalysed archived genomic data from [@ref-52] and a new transcriptomic dataset from chicks with FDM. The previously published microarray study ([@ref-52]) analysed retina and RPE tissue at 6 h and 72 h of FD myopia induction. This dataset was obtained from the Gene Expression Omnibus database (accession number [GSE6543](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6543)). This dataset was reanalysed using Gene Set Enrichment Analysis (GSEA) method in conjunction with our novel FDMR data using retina/RPE/choroid tissue following 10 days of translucent occlusion, at time of occluder removal and then at 6 h and 24 h post occlude removal. The RIDE model would predict that pathways associated with neurotransmission, metabolism and ion solute transport would be significantly perturbed

Gene Set Enrichment Analysis (GSEA) ([@ref-94]) has been utilized to identify key expression networks involved in induction of form-deprivation myopia (FDMI) and during early recovery from form-deprivation myopia (FDMR). GSEA was originally developed to identify consistent generalized differences in the cumulative distribution in the expression of genes in a biological pathway based on a priori knowledge of the gene's biological function ([@ref-94]). Unlike other pathway analyses, all genes within the expression dataset are considered irrespective of whether particular DEGs show statistically significant differences in gene expression as identified in previous analyses.

Materials and Methods
=====================

FD induction dataset
--------------------

Previously published microarray data from the [@ref-52] study were obtained from the GEO Database (<https://www.ncbi.nlm.nih.gov/geo/>; accession number [GSE6543](GSE6543)). The raw CEL files from this study were reanalysed to complement our FD recovery profile. Although many microarray studies have ascertained the transcriptome profile of refractive error development and its progression ([@ref-6]; [@ref-11]; [@ref-52]; [@ref-70]; [@ref-80]; [@ref-81]; [@ref-85]; [@ref-92]; [@ref-95]), all have used optical defocus or FD in other species. The [@ref-52] study is the most comparable to ours in that similar tissue was collected, i.e., chick Retina/RPE preparation, from FD animals and analysed using the same Affymetrix microarray chips. To accompany our re-analysis of this data, refraction and ocular biometrics were collected from 24 chickens that were monocularly occluded at one-week of age for 6 hr (*n* = 6) and 72 hr (*n* = 6) with an additional 12 chicks used as age-matched controls.

FD recovery dataset
-------------------

### Animals

Twenty hatchling chicks (*Leghorn x New Hampshire*) were utilised in this study. Fifteen chicks were form-deprived (FD) for 10 days (day 2-11 post-birth) by attaching a translucent polystyrene occluder to the periocular feathers of their right eye as previously described ([@ref-16]). Separate chicks were used as aged-matched unoccluded controls (*n* = 5). Occluders were removed on day 12 and chicks were given 0 hr (*n* = 5), 6 hr (*n* = 5) or 24 hr (*n* = 5) of normal vision to recover from form-deprivation. Chicks were raised with unlimited food and water in a controlled environment on a 12 h light/12 h dark cycle and with the temperature maintained at 30 ± 0.5 °C. Illuminance was maintained at 183 lux during the 12 h day cycle using a 20 W halogen lamp. All animal work in this study was approved by the La Trobe University Animal Ethics Committee (Approval No. 05/07) and is in accordance with the Guidelines for Use of Animals in Research by the National Health and Medical Research Council (NHMRC) of Australia and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

### Ocular refraction, biometric analysis

Refractive state (dioptres (D)), vitreous chamber depth (VCD in mm) and axial length (AL in mm) measures were collected from all animals (induction and recovery) while animals were surgically anesthetized with an intramuscular injection of ketamine (45 mg/kg) and xylazine (4.5 mg/kg). Refraction in the experimental right eyes were determined by trained ophthalmic practitioners using retinoscopy (Keeler, Vista Diagnostic Instruments, Malvern, PA, USA) and A-Scan ultrasonography (A-Scan III, TSL; Teknar, Inc. St Louis, USA; 7 MHz probe) was used to measure axial dimensions. Analyses of Variance (ANOVA) was used to test group differences in refraction, AL and VCD followed by post-hoc tests if required. All dependent variables met the assumption for equal variance (Levene's Test *p* \< 0.05).

### MRI imaging

MRI (4.7T) of chick FD for 10 days then given 72 h of normal visual experience was obtained to confirm our previous histological analysis ([@ref-46]) which has shown ∼300% increase in choroidal thickness in the FD eye compared to fellow eye. For this, chicks were stereotaxically immobilised under surgical anaesthesia in the small bore of the magnet. Chick heart rate was also monitored.

### Microarray tissue collection and RNA isolation

All chicks were euthanized by decapitation immediately after ocular measurements were taken. Right eyes were enucleated and the choroid/retina/RPE were taken from the posterior eye cup, placed in PrepProtect™ RNA stabilizing buffer (Miltenyi Biotec Australia Pty. Ltd., North Ryde, NSW, Australia) and stored on ice until transferred to −20 °C freezer. RNA was extracted using the SV total RNA isolation system (Promega Australia, NSW, Australia), including DNA digestion. The quality of the RNA samples was assessed via NanoDrop^®^ ND-1000 Spectrophotometer (ThermoFisher, Waltham, MA, USA) and found to fall within the acceptable absorbance (260/280) range of 1.8--2.1. For Affymetrix microarrays, RNA from the right-eyes of each animal (control and experimental) was pooled in equimolar amounts by experimental condition (control (*n* = 5), 0 hr (*n* = 5), 6 hr (*n* = 5) and 24 hr (*n* = 5)) and sent to the Australian Genome Research Facility Ltd (Walter and Eliza Hall Institute, Victoria, Australia) for microarray processing. Raw data were exported as CEL files containing probe level intensities for preprocessing with Expression Console™ 1.1 (Affymetrix, Inc, Santa Clara, CA, USA). This data has been submitted to GEO Database (<https://www.ncbi.nlm.nih.gov/geo/>; accession number [GSE89325](GSE89325)).

### Sample pooling

Pooling of RNA samples was chosen, as our primary aim was to identify altered biological pathways associated with experimental myopia using GSEA rather than single-gene analysis. GSEA assesses the collective changes in gene expression and identifies relevant biological pathways where these genes act ([@ref-51]; [@ref-94]). Pooling biological samples was originally discouraged for single gene analysis as pooling may preclude variance measures in downstream statistical analysis ([@ref-68]). Many later publications indicate that such caution is unnecessary as sample pooling does not impact negatively on identifying differentially expressed genes, particularly for small experiment designs and in animals within similar experimental manipulations ([@ref-10]; [@ref-28]; [@ref-53]; [@ref-60]; [@ref-109]). Furthermore, such limitations in sample pooling does not have impact on the reliability of the GSEA algorithm which requires at least a subset of genes within a pathway to be consistently ranked near the top or bottom of the ordered list rather than if single gene measures were used ([@ref-51]; [@ref-94]). In addition, to ensure the rigor of our analyses we used a more stringent statistical threshold of 0.05 for our analysis rather than the recommended 0.25 for GSEA ([@ref-51]; [@ref-94]).

Data pre-processing & normalisation
-----------------------------------

To determine if the differences in chicken strain and tissues used produced confounding results, we pre-processed the [GSE6543](GSE6543) and our Affymetrix chicken chip data (CEL files) individually and then together using Expression Console™ 1.1 (Affymetrix, Inc, Santa Clara, CA, USA). No significant outliers were found in either forms of pre-processing therefore we chose to present the data that was modelled together. Average background, RawQ, poly-A controls (*dap, lys, phe, thr, trp*) & hybridisation controls (*bioD, bioC, bioD, cre*) were assessed ([@ref-2]; [@ref-3]). The raw data was summarised and normalised using the Robust Multichip Average (RMA) algorithm to yield log base 2 expression values for each transcript. Expression values of genes with multiple probe sets were then median summarised, resulting in a total of 14,298 gene measures. Expression values of the FD induction samples were averaged by condition (6hr controls (*n* = 1), 6 hr FD (*n* = 1), 72 hr control (*n* = 1), 72 hr FD (*n* = 1)) to yield a single log2 expression value. This was done as FDMR tissue samples were pooled prior to microarray analysis and hence resulting in one sample (ie data point) per time-point.

Although all (i.e., induction and recovery) CEL files were modelled together, average background scores ranged from 56 to 114 for the FD induction data and from 62 to 89 for the FDMR dataset. These values are mostly consistent with Affymetrix recommendations of typical average background values falling between 20 to 100 ([@ref-2]). Poly-A controls were all present with average signal of *dap*\>*thr*\>*phe*\>*lys*. Hybridisation controls were also present with increasing signals which reflect their relative concentrations, specifically *cre*\>*bioD*\>*bioC*\>*bioB*. Ideally, arrays being compared should have comparable background values so these findings may have resulted from electrical noise rather than low sample quality as other parameters were consistent with manufacturer recommendations. Both GAPDH and EF1 *α* internal controls indicated that hybridisation fell within the parameters. Interestingly, the β-actin signal was above threshold for both datasets, possibly indicating that specific transcription of β-actin is altered in extreme myopia. Indeed, phototransduction requires actin filaments and microtubules to redistribute arrestin and transducin ([@ref-73]) making β-actin an unreliable housekeeping gene ([@ref-20]). Furthermore, our own ultrastructure studies have indicated redistribution of actin filaments in cells such as RPE and photoreceptors in form-deprivation ([@ref-46]). Thus, pre-processing of both datasets was rerun to mask the Affymetrix housekeeping probesets for β-actin. After median summarisation, the final dataset included 14,298 genes. A report of the parameters used in the pre-processing of both the [GSE6543](GSE6543) and our Affymetrix chicken chip datasets is included in [Table S1](#supp-2){ref-type="supplementary-material"}. Now available as GEO Database (<https://www.ncbi.nlm.nih.gov/geo/>; accession number [GSE89325](GSE89325)).

Gene set enrichment analysis
----------------------------

The Broad Institute's Gene Set Enrichment Analysis (GSEA) software was used to determine whether a priori defined sets of genes were significantly enriched ([@ref-55]; [@ref-94]) during the induction and recovery of FD. Curated gene sets were obtained from the Molecular Signature Database (MSigDB). In particular, annotated gene sets were sourced from three databases; BioCarta (<http://www.biocarta.com/genes/index.asp>), KEGG (<http://www.genome.jp/kegg/pathway.html>), and Reactome (<http://www.reactome.org/>) and chick genes were converted to human genes where possible ([Table S2](#supp-3){ref-type="supplementary-material"}). Pearson's correlation was used, being the recommended metric for time-series data ([@ref-12]) to assess changes in gene expression over the duration of occluder wear, both short-term (6 hr & 72 hr; [GSE6543](GSE6543)) and long-term FDMI which combined data from [GSE6543](GSE6543) (retina/RPE; 6 hr & 72 hr) and [GSE89325](GSE89325) (retina/RPE/choroid; 240 hr). Changes in gene expression was also assessed during the recovery after occluder removal (FDMR; 0 hr, 6 hr, & 24 hr). GSEA was also applied to the control samples (6 hr, 72 hr, & 240 hr) to determine developmental or tissue-specific expression profiles. Following GSEA, we performed leading-edge analysis which focuses on the core gene members that account for the gene set's enrichment signal as not all members of the gene-set will typically participate in a biological process underlying a disease phenotype. This means that the genes that contribute most to a given pathway's enrichment (i.e., core genes) will be located at the top (most upregulated) or bottom (most downregulated) of the ranked gene list ([@ref-94]).

To overcome gene-set redundancy and help in the interpretation of large pathway lists, clustering of GSEA results was then performed using EnrichmentMap ([@ref-54]) for each experimental group (normal development, FDMI and FDMR) and an overlap similarity coefficient cut-off of 0.5.

Results
=======

Ocular biometrics for FDMI and FDMR
-----------------------------------

We collected refractive state (Rx, D), vitreous chamber depth (VCD, mm) and axial length (AL, mm) measures for all timepoint conditions (FDMI, FDMR, control) as biometric measures were not available for McGlinn and colleagues' original microarray dataset at 6 hr and 72 hr of FDMI. Thus, the earlier biometric measures presented in [Fig. 2](#fig-2){ref-type="fig"} for 6 hr and 72 hr induction datasets were included to provide relative indicators of growth and refraction changes expected at that number of hours of occlusion.

![Ocular Biometrics for FDMI and FDMR.\
Mean (±SE) measures of refractive status, axial length (AL) and vitreous chamber depth (VCD). To complement the data reported by [@ref-52], (A) refraction and (B) AL & VCD were collected during 6 h and 72 h of normal development and 6 h and 72 h following seven-days induction of myopia. Refraction, AL & VCD measures for 24 h recovery after prolonged (i.e., 10 days) form deprivation is shown in (C) and (D). Both refractive state and axial length changes were highly correlated (*r* = .78) during occluder wear (E). Note: Measures for anterior chamber and lens thickness are included in [Fig. S1](#supp-5){ref-type="supplementary-material"}.](peerj-06-5048-g002){#fig-2}

In response to occluder wear, AL and VCD increased and refraction became more negative with time post-occlusion under our laboratory conditions. There was a significant main effect for FD induction on refraction \[*F*(1, 20) = 33.16, *p* \< .001\] and time \[*F*(1, 20) = 17.99, *p* \< .001\]. A significant interaction was also observed between FD and time \[*F*(1, 20) = 10.67, *p* \< .001\]. A significant main effect was observed for FD induction on axial length measurements \[*F*(1, 20) = 15.40, *p* \< .001\] and time \[*F*(1, 20) = 33.17, *p* \< .001\]. A significant main effect was observed for time for VCD \[*F*(1, 20) = 4.31, *p* \< .05\] but not for FD induction \[*F*(1, 20) = 3.61, *p* = .07\].

For our recovery dataset (10 d control, 10 d FDMI, 6 hr FDMR and 24 hr FDMR), biometric measurements and gene expression profiles were collected from the same chicks. Both refractive status and axial dimensions normalised rapidly following occluder removal and 24 hr of normal visual experience ([Fig. 2](#fig-2){ref-type="fig"}). These measures were shown to be highly correlated (*r* = .78; [Fig. 2E](#fig-2){ref-type="fig"}).

There was a significant main effect on refraction in FD recovery \[*F*(1, 20) = 1499.27, *p* \< .001\] and time \[*F*(2, 20) = 134.0, *p* \< .001\]. A significant interaction was also observed between FD and time \[*F*(2, 20) = 141.46, *p* \< .001\]. Post-hoc tests revealed that refraction was significantly different at all induction time-points (*p* \< .01) except between 10 days of occlusion (0 h) and 6 h recovery (*p* = .13). Axial length was significantly different for FD recovery \[*F*(1, 20) = 199.87, *p* \< .001\] and time \[*F*(2, 20) = 7.07, *p* \< .01\]. A significant main effect for FD was observed for VCD \[*F*(1, 20) = 146.49, *p* \< .001\] but no main effect was seen for time \[*F*(2, 20) = 2.275, *p* = .13\].

MRI of the FD chick at 72 hr post-recovery shows substantial retinal thinning and choroidal expansion. These observations confirm our previous histological work ([@ref-46]) where maximum choroidal expansion in the FD eye is approximately 300% greater than the fellow eye

Gene set enrichment analysis
----------------------------

To understand the underlying biological processes governing myopia development we performed pathways enrichment analysis using the Gene Set Enrichment Analysis (GSEA). We focused on identifying KEGG, Reactome, and BioCarta pathways showing expression shifts that correlated with the time post-FD by occlusion (in hours). We performed three separate analyses to deal with the complexity of the data including sample pooling. The first analysis involved normalised log expression data for short-term FD (6 hr and 72 hr) induction. The second dataset included averaged log expression for when data was collected during the combined long-term induction period (i.e., 6 hr, 72 hr, and 240 hr (10 d) for control and FDMI datasets) and thirdly, analysis was performed on average expression values during recovery post FD occlusion (i.e., 0 hr (post-occlusion), 6 hr, and 24 hr).

Enrichment analysis for short-term FDM induction
------------------------------------------------

Our initial analysis focused on identifying KEGG, Reactome, and BioCarta pathways showing expression shifts that correlated with short-term FD to compliment previous findings by [@ref-52]. Analysis of gene expression changes between 6 hr and 72 hr of FD revealed 13 significantly enriched pathways. Most pathways responding to short-term FD involve mitochondrial energy metabolism ([Table 1](#table-1){ref-type="table"}). Interestingly, none of the genes identified by [@ref-52] were listed as a core gene for these pathways suggesting that highly regulated genes are not always driving treatment-specific biological responses. Notably, genes involved in 'One carbon pool by folate' was significantly upregulated suggesting an association between homocysteine (Hcy) and B-vitamins in short-term FD induction. Genes associated with short-term FD induction have previously been associated with AMD ([@ref-30]).
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###### Pathways enriched between 6 h and 72 h of FD induction.

Mean Normalised Enrichment Score (NES) and false discovery rate (FDR) for the biological pathways identified by GSEA in FD induction. Most genes responding to FD are involved in mitochondrial energy metabolism. The NES reflects the degree to which a set of genes is over-represented at either the top or bottom of a ranked list of genes while also taking into account differences in pathway size (i.e. gene-set size) and is the primary statistic for examining enrichment results, and for comparing results across pathways.

![](peerj-06-5048-g011)

  Pathway                                                                                                            Core genes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Database   NES    FDR
  ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------- ------ ------
  Huntingtons disease                                                                                                APAF1, ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5H, ATP5O, BDNF, CASP3, CASP8, CLTA, COX4I1, COX5A, COX6A1, COX6C, COX7A2, COX7A2L, COX7C, COX8A, CYCS, DNAH3, DNAI1, DNAL1, DNALI1, GPX1, HDAC2, IFT57, NDUFA1, NDUFA10, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, PLCB1, PLCB4, POLR2D, POLR2F, POLR2J, POLR2L, PPID, SDHA, SLC25A4, SLC25A6, SOD2, TAF4, TBP, TBPL1, TFAM, UQCR10, UQCR11, UQCRFS1, UQCRH, VDAC3   KEGG       1.76   0.15
  Oxidative phosphorylation                                                                                          ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5H, ATP5I, ATP5J2, ATP5O, ATP6V0D2, ATP6V1G1, COX11, COX15, COX17, COX4I1, COX5A, COX6A1, COX6C, COX7A2, COX7A2L, COX7C, COX8A, NDUFA1, NDUFA10, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, PPA1, PPA2, SDHA, UQCR10, UQCR11, UQCRFS1, UQCRH                                                                                                                                  KEGG       1.81   0.16
  Mitochondrial protein import                                                                                       BCS1L, CHCHD4, COX17, DNAJC19, GRPEL1, HSCB, HSPD1, PAM16, PMPCA, PMPCB, SAMM50, SLC25A12, SLC25A4, SLC25A6, TIMM13, TIMM17A, TIMM22, TIMM44, TIMM9, TOMM22, TOMM5, TOMM7                                                                                                                                                                                                                                                                                                                                                                                    Reactome   1.80   0.16
  One carbon pool by folate                                                                                          ATIC, DHFR, GART, MTFMT, MTHFD1, MTHFD1L, MTHFS, TYMS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        KEGG       1.74   0.17
  Cholesterol biosynthesis                                                                                           DHCR7, FDFT1, GGPS1, HMGCR, HMGCS1, IDI1, MSMO1, NSDHL, SQLE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Reactome   1.77   0.17
  Antigen processing cross presentation                                                                              CD36, CTSS, NCF4, PSMA1, PSMA2, PSMA3, PSMA5, PSMA6, PSMA7, PSMB1, PSMB2, PSMB3, PSMC1, PSMC2, PSMC3, PSMC5, PSMD1, PSMD10, PSMD3, PSMD5, RPS27A, SEC61B, SEC61G, TAP1, UBA52                                                                                                                                                                                                                                                                                                                                                                                Reactome   1.74   0.18
  Alzheimers disease                                                                                                 NDUFB6, CYCS, NDUFB3, NDUFA8, UQCR11, NDUFC2, ATP5F1, ATP5E, NDUFB5, UQCR10, COX4I1, COX6A1, COX7C, NDUFB10, NDUFB1, CASP8, NDUFV3, NDUFA6, ATP5H, COX7A2, RYR3, NDUFA2, NDUFC1, NDUFS1, NDUFA1, SDHA, NDUFB8, NDUFA4, NDUFA5, APAF1, UQCRH, ATP5O, NDUFA7, NDUFS6, NDUFS4, ATP5D, ATP5C1, NDUFB9, CACNA1D, NDUFS8, NDUFS3, NDUFS7, CASP3, COX8A, COX6C, COX5A, NDUFA10, ATP2A1, COX7A2L, TNFRSF1A, UQCRFS1, PSEN1, NDUFB4, IL1B, PLCB1, NCSTN, PLCB4                                                                                                        KEGG       1.74   0.19
  Parkinsons disease                                                                                                 APAF1, ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5H, ATP5O, CASP3, COX4I1, COX5A, COX6A1, COX6C, COX7A2, COX7A2L, COX7C, COX8A, CYCS, GPR37, NDUFA1, NDUFA10, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, PARK7, PPID, SDHA, SLC25A4, SNCAIP, UBE2L3, UQCR10, UQCR11, UQCRH, VDAC3                                                                                                                                               KEGG       1.77   0.19
  TCA cycle and respiratory electron transport                                                                       ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5H, ATP5I, ATP5J2, ATP5O, COX4I1, COX5A, COX6A1, COX6C, COX7A2L, COX7C, COX8A, CYCS, D2HGDH, DLD, IDH3A, LDHB, NDUFA1, NDUFA10, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, NNT, SDHA, SUCLG1, SUCLG2, UQCR11, UQCRH                                                                                                                                                                   Reactome   1.72   0.19
  Respiratory electron transport                                                                                     COX4I1, COX5A, COX6A1, COX6C, COX7A2L, COX7C, COX8A, CYCS, NDUFA1, NDUFA10, NDUFA12, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, SDHA, UQCR11, UQCRFS1, UQCRH                                                                                                                                                                                                                                                   Reactome   1.81   0.21
  Respiratory electron transport ATP synthesis by chemiosmotic coupling and heat production by uncoupling proteins   ATP5C1, ATP5D, ATP5E, ATP5F1, ATP5H, ATP5I, ATP5J2, ATP5O, COX4I1, COX5A, COX6A1, COX6C, COX7A2L, COX7C, COX8A, CYCS, NDUFA1, NDUFA10, NDUFA12, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFB1, NDUFB10, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV3, SDHA, UCP3, UQCR11, UQCRFS1, UQCRH                                                                                                                                                                                  Reactome   1.83   0.23
  Translation                                                                                                        EEF1B2, EIF2B1, EIF2B2, EIF2S1, EIF2S2, EIF2S3, EIF3D, EIF3H, EIF3I, EIF3J, EIF4EBP1, EIF4H, EIF5B, RPL10A, RPL11, RPL13, RPL14, RPL18A, RPL19, RPL21, RPL22, RPL23A, RPL24, RPL26L1, RPL27, RPL27A, RPL29, RPL30, RPL32, RPL35, RPL35A, RPL36, RPL36A, RPL37, RPL37A, RPL38, RPL39, RPL5, RPL6, RPL7, RPL8, RPLP1, RPLP2, RPN1, RPS10, RPS11, RPS14, RPS15, RPS15A, RPS16, RPS2, RPS20, RPS23, RPS24, RPS25, RPS26, RPS27A, RPS28, RPS29, RPS3, RPS3A, RPS4X, RPS6, RPS7, RPS8, RPSA, SEC61B, SEC61G, SPCS1, SPCS2, SPCS3, SRP19, SRP72, SSR3, UBA52        Reactome   1.69   0.24
  ER phagosome pathway                                                                                               PSMA1, PSMA2, PSMA3, PSMA5, PSMA6, PSMA7, PSMB1, PSMB2, PSMB3, PSMC1, PSMC2, PSMC3, PSMC5, PSMD1, PSMD10, PSMD3, PSMD5, RPS27A, SEC61B, SEC61G, TAP1, UBA52                                                                                                                                                                                                                                                                                                                                                                                                  Reactome   1.67   0.25

Enrichment analysis for long-term FDM induction (FDMI) and recovery (FDMR)
--------------------------------------------------------------------------

We next performed GSEA to identify KEGG, Reactome, and BioCarta pathways showing expression shifts that correlated with longer-term FD by occlusion (in hours; 6 hr, 72 hr, and 240 hr (10 d) for control and FDMI datasets; and 0 hr (post-occlusion), 6 hr, and 24 hr for the FDMR dataset. This analysis identified 61 significantly enriched pathways during normal development, 130 during FDMI, and one during FDMR. We then used the Enrichment Map ([@ref-54]) to cluster highly similar pathways into networks. Many pathways were implicated during both normal (control) development and FDMI suggesting that most of these pathways are likely to relate more to rate of growth rather than to the form-deprivation paradigm *per se.* That is, given that the same pathways were identified irrespective of the experimental manipulation it is likely that similar mechanisms associated with growth are likely to operate under any experimental conditions. The direction of regulation i.e., up or down, would be expected to be associated with rates of growth and with the age of the chicks and would be predicted by the RIDE model. Summary statistics for the resulting clusters are presented in [Table 2](#table-2){ref-type="table"}, and the clusters are visualized in [Figs. 3](#fig-3){ref-type="fig"} and [4](#fig-4){ref-type="fig"}.

10.7717/peerj.5048/table-2

###### Summary statistics for clusters of pathways enriched during FDMI and normal development.

Mean Normalised Enrichment Score (NES), false discovery rate (FDR) and signal strength statistic (Signal) for the biological pathways implicated by GSEA in control and FDM. Normal eye development implicated 10 cluster of pathways showing average signal strength while form-deprivation induction implicated 18 clusters of pathways. Pathways shown here only include clustered pathways as represented in [Figs. 3](#fig-3){ref-type="fig"} and [4](#fig-4){ref-type="fig"} and do not include pathways that were unclustered. Further detail on the unclustered pathways can be found in [File 1](#supp-1){ref-type="supplementary-material"}. The NES reflects the degree to which a set of genes is overrepresented at either the top or bottom of a ranked list of genes while also taking into account differences in pathway size (i.e., geneset size). NES is the primary statistic for examining enrichment results, and for comparing results across pathways. The percentage signal strength statistic reflects the proportion of the core set of genes that contribute most to a given pathway's enrichment by accounting for particular genes position in the ranked list. A high signal strength indicates that the genes within a pathway are located close to the top (positive NES) or bottom (negative NES) of the ranked gene list. If the core genes are spread throughout the ranked list, then the signal strength decreases towards zero ([@ref-55]; [@ref-94]).

![](peerj-06-5048-g012)

  Cluster                                                         Control   FDMI                                         
  --------------------------------------------------------------- --------- -------- ------- ----- ---- -------- ------- ------
  Cell cycle, mitotic                                             5         −2.233   0.019   31%   3    −2.253   0.009   98%
  Cell maintenance & survival                                     --        --       --      --    28   −2.180   0.014   117%
  Clatherin-mediated endocytosis (CME)                            --        --       --      --    2    −2.014   0.032   81%
  Complement and coagulation cascades (CCC)                       --        --       --      --    2    2.708    0.003   140%
  Cytochrome p450                                                 2         2.247    0.025   47%   5    2.629    0.002   133%
  Cytokine pathways                                               2         2.717    0.002   40%   --   --       --      --
  Neuron structure/growth                                         --        --       --      --    5    −2.321   0.007   80%
  Fatty acid (FA) metabolism                                      --        --       --      --    2    −1.886   0.032   84%
  Glucosaminoglycan (GAG) metabolism                              4         2.121    0.029   40%   --   --       --      --
  Ion channel transport                                           --        --       --      --    2    −2.331   0.007   99%
  Mitochondrial energy metabolism                                 --        --       --      --    7    2.396    0.005   47%
  Neurotransmission                                               5         −2.522   0.011   37%   8    −2.423   0.007   103%
  Peroxisome                                                      2         −2.221   0.017   40%   --   --       --      --
  Phospholipid metabolism                                         2         −2.134   0.026   28%   3    −1.939   0.027   57%
  Signal transduction, growth factors (GF)                        --        --       --      --    4    −1.984   0.021   66%
  Signal transduction, g-protein coupled receptors (GPCR)         7         2.572    0.019   52%   7    2.683    0.010   122%
  Signal transduction, mitogen-activated protein kinases (MAPK)   --        --       --      --    4    −1.931   0.028   67%
  Signal transduction, nerve growth factor (NGF)                  --        --       --      --    5    −2.195   0.014   84%
  Transcription                                                   --        --       --      --    10   −2.218   0.013   120%
  Translation                                                     --        --       --      --    8    2.731    0.001   46%
  Ubiquitin-mediated proteolysis                                  3         −2.491   0.006   39%   --   --       --      --
  Vesicle-mediated transport                                      3         −2.152   0.025   40%   3    −2.097   0.013   103%

![Enrichment map for highly clustered pathways in normal eye development.\
Gene set enrichment analysis revealed 61 biological pathways that can be functionally grouped into 10 clusters using a co-efficient of similarity altered during the 10 days of normal eye development in retina/RPE/choroid. *Note:* Each node represents a biological pathway from [File S1](#supp-1){ref-type="supplementary-material"}. The colour of each node emphasises the direction of expression and normalised enrichment score (NES). Node size is relative to the number of genes in the pathway. Thickness of the connections (green) between each node reflects the degree of similarity between each gene set. Twenty-six pathways did not meet the clustering similarity coefficient of 0.5 and hence are not shown here. *Note cluster names: GAG, glycosaminoglycan; GPCR, g-protein coupled receptors.*](peerj-06-5048-g003){#fig-3}

![Enrichment map for highly clustered pathways in form deprivation induction and recovery.\
Axial elongation during 10 days of form-deprivation compared to normal unoccluded controls resulted in 130 altered pathways in retina/RPE choroid (inner node) while 24 h recovery (outer annulus) identified only one statistically significant pathway i.e., bile acid & bile salt metabolism. Pathways not statistically enriched during FDMR are shown for comparison purposes. Notably, expression profiles of FDMI and FDMR are consistent despite the fact that only the FDMR data includes choroidal tissue. Pathways highly expressed during induction (red inner node) were often suppressed during normal vision and recovery (blue outer annulus) and vice versa. *Note:* Each node represents a biological pathway from [File S1](#supp-1){ref-type="supplementary-material"}. The colour of each node emphasises the direction of expression and normalised enrichment score (NES). Node size is relative to the number of genes in the pathway. Thickness of the connections (green) between each node reflects the degree of similarity between each gene set. There were 22 unclustered pathways in FDMI that did not meet the clustering similarity coefficient of 0.5. *Note cluster names: CCC, complement and coagulation cascades; CME, clatherin-mediated endocytosis; FA, Fatty acid; GF, growth factors; GPCR, g-protein coupled receptors; MAPK, mitogen-activated protein kinases; NGF, nerve growth factor.*](peerj-06-5048-g004){#fig-4}

FDMI was characterised by 19 clusters of pathways ([Fig. 4](#fig-4){ref-type="fig"}). Six of these clusters were also altered during normal ocular development ('cell cycle, mitotic', 'cytochrome p450', 'neurotransmission', 'phospholipid metabolism', 'signal transduction, GPCR' and 'vesicle-mediated transport') but demonstrate greater signal strength during FDMI compared to normal development ([Table 2](#table-2){ref-type="table"}). The direction of expression change for these clusters is consistent across both normal development and FDMI.

Leading edge analysis
---------------------

We next examined the leading-edge subsets (i.e., core genes) within the clusters identified during FDMI, for potential genes that may play a role in the broader ultrastructural evidence of oxidative and hyperosmotic stress previously described during FDM ([@ref-16]; [@ref-45]; [@ref-46]) and in brain ([@ref-13]; [@ref-58]; [@ref-97]). These clusters included mitochondrial metabolism gene sets previously identified by [@ref-77] in similar aged chicks with refractive errors induced by optical defocus.

Gene sets involved in maintaining mitochondrial metabolism (oxidative phosphorylation, TCA cycle and respiratory electron transport/ATP synthesis) or diseases involving mitochondrial dysfunction (i.e., Huntington's disease, Parkinson's and Alzheimer's Diseases) were significantly upregulated during short-term FDM ([Table 1](#table-1){ref-type="table"}) and long-term FDMI (NES = 2.40, *p* = .005; [Table 2](#table-2){ref-type="table"}), and displayed non-significant down-regulation during the 24 hr period of FDMR ([Fig. 4](#fig-4){ref-type="fig"}). [Figure 5](#fig-5){ref-type="fig"} illustrates the relative changes in these particular pathways at different time-points. By comparison, there were no significant changes in expression of these mitochondrial metabolism pathways during normal ocular development ([Table 2](#table-2){ref-type="table"}). This shift in metabolic regulation during induction of FDM and recovery is reminiscent of the bidirectional regulation of metabolic genes described for signed optical defocus by ([@ref-77]).

![Median expression of pathways involved in mitochondrial metabolism.\
Graphs of the seven mitochondrial metabolism pathways with significant expression shifts across 240 h of occluder wear relative to unoccluded controls (A) Alzheimer's disease, (B) Huntington's disease, (C) Parkinson's disease, (D) Oxidative phosphorylation, (E) Respiratory electron transport, (F) Respiratory electron transport/ATP synthesis by chemiosmotic coupling and heat production by uncoupling proteins, (G) TCA cycle and respiratory electron transport.](peerj-06-5048-g005){#fig-5}

Examination of the leading-edge subsets (i.e., core genes) of the mitochondrial metabolism pathways revealed 72 high scoring core genes that contributed to its significance during FDMI ([File S1B](#supp-1){ref-type="supplementary-material"}). Fourteen of these core genes are present in all mitochondrial energy metabolism gene sets and form part of mitochondrial complex I (NDUFA1, NDUFA4, NDUFA5, NDUFA6, NDUFB1, NDUFB3, NDUFB6, NDUFB9, NDUFS2, NDUFS3, NDUFS7), complex III (UQCR11, UQCRH) and complex IV (COX7C). Both complex I and III are primary producers of reactive oxygen species (ROS) in neural tissues resulting in oxidative stress when cells are unable to stabilise the ROS ([@ref-59]). Furthermore, an additional 11 core genes were present in six out of seven gene sets with a majority coding for mitochondrial complex V subunits that catalyse the conversion of adenosine diphosphate (ADP) and inorganic phosphate (Pi) to ATP. Taken together, these data strongly implicate mitochondrial metabolism in the physiology of myopia.

A similar analysis of leading edge subsets relating to neurotransmission demonstrated significant negative correlations with duration of occluder wear (NES =  − 2.42, *p* = 0.007; [Table 2](#table-2){ref-type="table"} and [Fig. 6](#fig-6){ref-type="fig"}). While these pathways showed transcriptional activation during FDMR, they did not reach the FDR cut-off of 0.05 during the short recovery period.

![Median expression of pathways involved in neurotransmission during normal ocular development and in FDMI.\
Graphs of the neurotransmission-related pathways with significant expression shifts during normal ocular development (dotted lines) and FDMI (solid lines) are shown. (A--D) Four pathways were significant in both normal development and FDMI. The leading-edge subsets for these pathways identified 115 common core genes shared within these pathways during normal development and during FDMI and 27 other core genes specific to normal development and nine specific to FDMI ([File S1](#supp-1){ref-type="supplementary-material"}). (E--H) Graphs indicate FDMI induced down regulation of expression shift in four additional neurotransmission-related pathways with significant expression shifts during FDMI (solid lines) only. These pathways were not significant during normal ocular development but data are shown for comparison purposes (dotted lines). (A) Neuronal system (B) Neurotransmitter release cycle (C) Neurotransmitter receptor binding & downstream transmission in the postsynaptic cell (D) Transmission across chemical synapse (E) Activation of NMDA receptor upon glutamate binding and postsynaptic events (F) CREB phosphorylation through the activation of RAS (G) Long-term potentiation (H) Post-NMDA receptor activation events.](peerj-06-5048-g006){#fig-6}

Five neurotransmission-related gene sets also reported significant expression shifts during normal ocular development ([Table 2](#table-2){ref-type="table"}; [Fig. 6](#fig-6){ref-type="fig"}). The significance in enrichment of these pathways during normal eye development was the result of 124 core genes with 10 genes common in four out of five pathways (ARHGEF9, GABRA1, GABRA2, GABRA6, GABRB2, GABRB3, GABRG2, GABRG3, GABRR1, GABRR2; [File S1A](#supp-1){ref-type="supplementary-material"}). In long-term FDMI, the signal strength rose to 103% ([Table 2](#table-2){ref-type="table"}) for neurotransmission for which there were 139 core genes (seven genes common in seven out of eight pathways). The seven genes in FDMI were serine/threonine protein kinases (BRAF, CAMK2B), ionotropic NMDA glutamate receptors (GRIN1, GRIN2A), mitogen-activated protein kinase (MAPK1) and ribosomal protein S6 kinase (RPS6KA2, RPS6KA6). In conjunction with a decrease in neurotransmission, analysis revealed suppression in clatherin-mediated endocytosis during FDMI (NES = − 2.014, *p* = 0.032; [Table 2](#table-2){ref-type="table"}) suggesting that prolonged FDMI results in a suppression in synaptic transmission.

Notably, a cluster of two ion-transport related pathways showed commonalities in genes which in turn were negatively correlated with long-term occluder wear ([Fig. 7](#fig-7){ref-type="fig"}). Indeed, the 'ligand-gated ion channel' pathway was clustered with the neurotransmission-related pathways during normal development. The leading-edge analysis identified 15 genes that contribute to the enrichment of these pathways (ARHGEF9, GABRA1, GABRA2, GABRA5, GABRA6, GABRB2, GABRB3, GABRG2, GABRG3, GABRR1, GABRR2, GLRA1, GLRA2, GLRA3, GLRB) implicating chloride currents in the development of form-deprivation myopia ([@ref-108]). This is of particular interest, as one of the aims of this study was to determine if pathways related to the mitochondrial abnormalities and ion redistribution patterns observed in our previous ultrastructural and elemental microanalysis work ([@ref-16]; [@ref-46]; [@ref-47]) were also identifiable using the GSEA approach to microarray data.

![Median expression of pathways involved in ion transport during normal ocular development and in FDMI.\
Expression of the (A) Ion channel transport and (B) Ligand-gated ion channel transport pathways with significant expression shifts during FDMI (solid lines) compared to normal development (dotted lines) are shown. The '*Ligand-gated ion channel transport pathway*' pathway was also significantly altered during normal development and was clustered with the neurotransmission pathway.](peerj-06-5048-g007){#fig-7}

Novel pathways associated with long-term FDMI as identified by GSEA
-------------------------------------------------------------------

### Complement and coagulation cascades

The strongest median signal of 140% and NES of 2.71 during FDMI ([Table 2](#table-2){ref-type="table"}) was found for two pathways involved in the complement and coagulation cascades ([Fig. 8](#fig-8){ref-type="fig"}). The Reactome '*Complement and coagulation cascade'* pathway was one of the two pathways within this cluster also significantly upregulated in controls (NES = 2.63, *p* = .001). The core genes contributing to the upregulation of this cluster of gene sets include 49 genes, with only 17 of these genes recurrent throughout this cluster. These include alpha-2-macroglobulin (A2M), coagulation factors (F2, F3, F7, F8, F9, F10, F11, F13A1, F13B), fibrinogen (FGA, FGG), kininogen (KNG1), serpins (SERPINC1, SERPING1), thrombomodulin (THBD) and von Willebrand factor (VWF).

![Median expression of pathways involved in the complement and coagulation cascade.\
Graphs indicate greater expression shift in the complement & coagulation cascade between 72 h and 240 h of occluder wear for both (A) formation of fibrin clot/clotting cascade and (B) complement and coagulation cascades. Note that the '*complement and coagulation cascades'* pathway was also significantly altered during normal development.](peerj-06-5048-g008){#fig-8}

### Cytochrome p450

This cluster of gene sets produced the second highest median signal (133%) during FDMI with an NES of 2.63 ([Table 2](#table-2){ref-type="table"}; [Fig. 9](#fig-9){ref-type="fig"}). The core genes underlying the upregulation of this cluster of pathways include the monooxygenases CYP1A2, CYP2C18, CYP3A4, and CYP3A7 that are found in the endoplasmic reticulum ([@ref-65]) and present in all five pathways within this cluster ([File S1B](#supp-1){ref-type="supplementary-material"}). The role of cytochrome p450 is in xenobiotic metabolism and subsequent synthesis of cholesterol, steroids and other lipids ([@ref-62]). Expression of CYP1A2 is induced by the aryl hydrocarbon receptor (AHR) and HIF 1 beta ([@ref-61]; [@ref-91]). Interestingly, CYP1A1 has been reported to be involved in retinoic acid (RA) biosynthesis where manipulation of the AHR gene results in reduced retinoic acid metabolism ([@ref-5]). This is an interesting finding as CYP7A1 and CYP8B1 have also been identified as core genes in bile acid metabolism during FDMR, and are inhibited by RA ([@ref-102]). CYP3A4 and CYP3A7 but not CYP2C18 have been shown to be suppressed in the presence of inflammatory cytokines ([@ref-4]). Therefore, dysregulation of cytochrome p450 is likely to have implications for presence of oxidative stress, endoplasmic reticulum stress and, if persistent, to be a serious risk factor for myopia and more severe ophthalmic disease.

![Median expression of pathways involved in cytochrome p450 metabolism.\
Graph indicates enhanced expression in cytochrome p450 related pathways in FDMI compared to normal development. (A) Biological oxidations (B) Cytochrome P450 arranged by substrate type (C) Drug metabolism, cytochrome P450 (D) Drug metabolism of xenobiotics by cytochrome P450 (E) Phase 1 functionalization of compounds.](peerj-06-5048-g009){#fig-9}

GSEA of recovery from FDM
-------------------------

GSEA to identify KEGG, Reactome, and BioCarta pathways showing expression shifts that correlated with recovery from FD by occlusion (in hours; 6 hr and 240 hr) was also performed. The only gene set significantly altered during the first 24 h of refractive recovery was the bile acid and bile salt metabolism pathway. Bile acid synthesis is reliant on the interaction of peroxisome degradation and mitochondrial metabolism with the end products of cholesterol utilization being the bile acids ([@ref-44]). Indeed, the synthesis of the bile acids is the major pathway of cholesterol catabolism in mammals. The 14 core genes involved include SLC10A1, ACOX2, AKR1D1, FABP6, CH25H, ABCC3, HSD17B4, ALB, ABCB11, CYP7B1, HSD3B7, SLCO1A2, AMACR, and CYP46A1 ([Fig. 10](#fig-10){ref-type="fig"}). SLC10A1 (sodium taurocholate cotransporting polypeptide), SLCO1A2 (sodium-independent Organic anion transporter), and cytochrome P450 genes, CYP7B1 and CYP46A1 are known to be involved with cholesterol pathways in brain. Other genes involved include protein members of the superfamily of ATP-binding cassette (ABC) transporters ABCC3, bile salt export pump ABCB11, and peroxisome genes acyl-coenzyme A oxidase 2 (ACOX2), and hydroxysteroid (17-beta) dehydrogenase 4 (HSD17B4).

![Median expression of core genes in the bile acid and bile salt metabolism pathway during FDM.\
Graphs shows median change of the core genes during normal ocular development, FDMI, and FDMR. This pathway was found to be significant for FDMI (left, solid line) and FDMR (right, solid line) but not in normal development. Note: Median expression value was calculated based on core genes identified in each experimental group. This pathway was not significantly altered during normal ocular development but data are shown for comparison purposes (dotted line).](peerj-06-5048-g010){#fig-10}

### Gene validation

The microarray results described here are consistent with our previously published work using RNA-seq ([@ref-77]). Hence, we chose not to validate core genes from each pathway by qPCR or other molecular technique as there are \>130 pathways identified in this study. Furthermore, validation of the core genes using qPCR is often questionable as it is reportedly subject to within-lab and technical differences (microarray vs qPCR) ([@ref-63]). Microarrays have been shown to exhibit good sensitivity and specificity in detecting gene expression changes ([@ref-17]) and perform comparatively to RNA-seq, as indicated above in our lab particularly ([@ref-77]). Additionally, single-gene analysis will not confirm significance of biological pathways identified in GSEA. For example, in the FDMI dataset, EIF4EBP1 was highly ranked at the top of the gene list for GSEA (i.e., highly upregulated; see [Table S3](#supp-4){ref-type="supplementary-material"}). This gene was only identified as a core gene in the 'Translation' pathway. A gene that was highly ranked at the bottom of the list (i.e., highly down regulated) was GDAP1. Interestingly, this gene was not listed as a core gene for any of the significant pathways identified by GSEA suggesting that highly regulated genes are not always responsible for driving treatment-specific biological responses.

Discussion
==========

Application of the GSEA technique to the existing FDMI microarray data sets and to our new FDMR dataset demonstrate generalized statistical differences in gene pathways. Mitochondrial energy metabolism was the predominant pathway upregulated in both short-term and long-term FDMI. Long-term FDMI resulted in further dysregulation in several pathways including suppression of neurotransmission, neuron structure/growth and subsequent ion transport compared to normal development. Complement pathways were also upregulated significantly over the time of form-deprivation. Furthermore, the only pathway significantly altered during the first 24 h of refractive recovery was the bile acid and bile salt metabolism pathway. This pathway is reliant on the interaction of peroxisome degradation, fatty acid and mitochondrial metabolism ([@ref-69]) and is consistent with the downregulation of fatty acid and PPAR pathways observed in chicks after one day of positive-lens defocus ([@ref-77]).

The identification of significantly upregulated mitochondrial energy metabolism pathways is an important finding. While there was a tendency towards upregulation of the mitochondrial energy metabolism pathway during normal development, these pathways were consistently upregulated immediately after the induction of occlusion and then gradually increased again in expression during later FDMI times ([Figs. 4](#fig-4){ref-type="fig"} and [5](#fig-5){ref-type="fig"}) as refractive compensation and growth rates normalized. The upregulation in mitochondrial energy pathways over the 10 days of FDMI was not unexpected given previous ultrastructural evidence of abnormal photoreceptor elongation and mitochondrial loss of integrity ([@ref-7]; [@ref-45]; [@ref-46]), and expression studies providing evidence for altered energy metabolism ([@ref-76]; [@ref-77]) and oxidative stress ([@ref-27]; [@ref-75]) in myopia.

The leading-edge genes identified as responsible for the change in these pathways primarily code for the mitochondrial complexes I and III that are primary producers of ROS in the brain and are associated with inability to stabilise ROS. Such instability is known to result in oxidative stress ([@ref-27]; [@ref-59]) which is a likely explanation for the cellular and mitochondrial damage in the retina previously demonstrated ultrastructurally in the FDM model ([@ref-46]; [@ref-47]). Defects in mitochondrial complexes I and III as a result of increased superoxide and other reactive oxygen species production ([@ref-1]) have also been shown to lead to neurodegeneration and subsequent vision loss ([@ref-107]). Indeed, this finding is consistent with recently published evidence of increased expression of TCA cycle and mitochondrial metabolism genes following negative-lens wear in chicks ([@ref-77]) and disruptions to TCA cycle metabolite abundance following FDMI in guinea pigs ([@ref-104]) further cementing the importance of the mitochondrial respiratory electron transport chain machinery in myopia development.

GSEA also demonstrated a greater number of suppressed transcription and signal transduction pathways during FDMI ([Fig. 4](#fig-4){ref-type="fig"}) compared to normal development ([Fig. 3](#fig-3){ref-type="fig"}). The presence of cell maintenance and survival pathways identified during FDMI suggests coordinated interactions between transcription factors, cell cycle components, and signalling molecules ([@ref-78]), as would be expected to change in a system responding to external stimuli. The majority of genes underlying the transcriptional events in FDMI were proteasome subunit genes ([File S1B](#supp-1){ref-type="supplementary-material"}). The fact that these genes were suppressed during occluder wear and reduced blood flow further highlights a system under severe physiological and oxidative stress as activation of the proteasome promotes cell survival against ROS-mediated oxidative stress ([@ref-14]) as predicted by the RIDE model.

Recent evidence has also suggested a role for ROS in signal transduction by mediating a variety of cellular processes ([@ref-84]) including the regulation of neurotransmission ([@ref-101]), NMDA receptor-mediated plasticity (reviewed in [@ref-9]), modification of ion transport mechanisms (Cl channels and cell swelling ([@ref-48])), endoplasmic reticulum (ER) stress and apoptosis by inhibiting WNT activation ([@ref-86]). Indeed, when mitochondrial metabolic pathways were upregulated during FDMI, NMDA-mediated signalling and ion transport pathways appeared down-regulated, implicating altered glutamate and glycine signalling, water transport and chloride distribution during FDMI. This NMDA signalling has previously been implicated in ocular growth control in experimental myopia ([@ref-25]; [@ref-26]) and together are predicted by the RIDE model.

Accumulating evidence suggests co-influencing roles between oxidative stress and one-carbon metabolism (1-C). In a mouse model of Parkinson's disease, high Hcy levels inhibited mitochondrial complex 1 activity subsequently leading to an increase in oxidative stress and loss of dopaminergic neurons in the substantia nigra ([@ref-67]). These findings may have implications in the current understanding of the role of dopamine in myopia ([@ref-113]). Folate deficiency has been associated with many ocular abnormalities including ectopic lentis, secondary glaucoma, optic atrophy, retinal detachment, cataracts, retinal vascular occlusive disease ([@ref-71]) and AMD ([@ref-30]). In astronauts, high Hyc and low folate levels are associated with ophthalmic changes after space flight ([@ref-114]). The microgravity-fluid shifts experienced by astronauts during space flights result in greater choroidal expansion, refractive changes and abrupt increases in IOP ([@ref-43]) similar to that observed in the chick model of FDM ([@ref-46]) further supporting the RIDE model ([@ref-15]; [@ref-16]). It is not yet known whether treatment with folic acid will reverse ocular abnormalities where Hcy is elevated however Hcy levels may be an early indicator of myopia ([@ref-106]).

The identification of the complement and coagulation cascade as having highest signal strength in comparison to other clusters during prolonged occlusion and induction of FDM implicates previously described physiological stress mechanisms associated with constriction of the choroid and reduced blood flow ([@ref-89]). This is an important result as the relationship between complement factors and myopia has only been reported once in humans ([@ref-49]) and in the cells from posterior sclera of experimentally-induced myopia in guinea pigs ([@ref-29]). More recently, a meta-analysis has suggested a role for the complement system in experimental myopia ([@ref-75]). Notably one of the core genes identified in this pathway was serpin peptidase G (C1 inhibitor; SERPING1), which is reported to function to maintain blood vessel integrity by binding to F12a (not identified in this study) and inhibiting Bradykinin ([@ref-19]), a protein that promotes inflammation by increasing the permeability of blood vessel walls ([@ref-31]) and calcium-dependent release of glutamate from astrocytes ([@ref-66]). Interestingly, Bradykinin Receptor B2 (BDKRB2) is also a highly frequent core gene identified in the complement cluster and in the GPCR cluster. Taken together, the regulation of SERPING1 and BDKRB2 may explain the presence of edema and structural changes in the FDMI eye, possibly resulting from the increase in blood vessel permeability during constriction of the choroid via BDKRB2. BDKRB2 has frequently been associated with brain edema, fluid leakage, signaling by GPCR and regulation of actin cytoskeleton and potentially may allow fluids to leak into the retina/vitreous as seen in pathological myopia ([@ref-27]). Deficiencies in SERPING1 have also previously been shown to occur in age-related macular degeneration ([@ref-22]).

The identification of bile acid metabolism as the only statistically significant change during FDMI was not predicted but is compatible with all omics results implicating energy, metabolic and ion transport ([@ref-38]; [@ref-41]; [@ref-74]; [@ref-92]; [@ref-98]) and ultrastructural fluid movements ([@ref-38]; [@ref-41]; [@ref-74]; [@ref-92]; [@ref-98]). The finding may be due to the acute time points selected for analysis given that previous ultrastructural descriptions have demonstrated that minimal change in choroidal thickness occurs prior to 72 h after occluder removal ([@ref-46]; [@ref-47]). This finding is not inconsistent with our conceptualisation of FDMR in an eye that has been under physiological stress for 10 days. Recent reports ([@ref-44]; [@ref-90]) also indicate that bile acids regulate not only their own synthesis, but also triglyceride, cholesterol, glucose, and energy homeostasis and play a role in osmoregulation. Bile acid synthesis has also been shown to be inhibited by all-trans retinoic acid by down regulating key bile acid synthesis and metabolism enzymes, such as cytochrome oxidase (CYP7A1, CYP8B1), ion transport (SLC27A5 and AKRLD1) ([@ref-50]; [@ref-102]) and closely associated with clock genes, metabolism and epigenetic regulators ([@ref-24]).

The two main limitations of this study are the use of the two types of tissue (retina/RPE and retina/RPE/choroid) and as discussed, the consideration of variance in gene expression between the [GSE6543](GSE6543) dataset and [GSE89325](GSE89325) dataset due to sample pooling. Our lab has previously assessed the impact of using a combination of ocular tissue in large scale genomic and proteomic studies ([@ref-74]) and found that regardless of the varying combinations of tissues used in studies of myopia, both FD and optical defocus, similar biological mechanisms were identified. Such similarity in identified biological mechanisms suggests that responses to environmental manipulation that reduces focused visual information is to elicit perturbation of the growth response by the whole eye across multiple tissue layers though originating in the photoreceptor layer and regardless of tissue properties and functions. However, tissue type is not a factor for GSEA as the analysis aims to assess combined changes in expression of genes within biological networks. Furthermore, gene analysis of separate ocular tissue compared to combined tissues show differing expression patterns may confer misleading results. For example, the gene BMP2 that [@ref-111] reported as mainly localised in the retina of chick, has previously been identified as a potential risk factor for myopia in chick retina/RPE ([@ref-52]) and in chick RPE ([@ref-111]). In a further cohort by the same lab ([@ref-110]), BMP2 was reported as non-significantly expressed in chick retina. Such contradictory results raise issues about the independence of differential gene signalling by BMP2 suggesting that BMP2 perturbation may be more related to other genes responding to the visual manipulation. In fact, our GSEA analysis that assesses the collective gene expression changes in all genes within all known biological pathways has identified BMP2 as a core gene for the immunological cytokine-cytokine receptor interaction pathway. This suggests that BMP2 is possibly functioning as a modulator for inflammation rather than influencing the growth signal ([@ref-36]) in the development of myopia. Thus we contend that pooling RNA from multiple tissues is not an impediment to our GSEA based interpretation as evidenced by the robustness of our current findings with many commonalities between FDMI and FDMR and between the different methodologies and much previous research in human and animals.

Conclusions
===========

We believe our analyses demonstrate that GSEA is a valuable tool in identifying altered biological pathways in the chick model of refractive error, as well as providing greater statistical power in identifying biological pathways not otherwise considered to be of potential significance. A major strength with GSEA is the generation of further hypotheses related to the understanding that many genes within a biological pathway can contribute to the underlying biology of a disease ([@ref-96]). Our findings demonstrate that gene pathway changes in mitochondrial energy metabolism, neurotransmission and subsequent involvement of ion homeostasis are tightly coupled to axial length and refraction changes as early as 6 h and 72 h after application of FD. The suppression in bile acid metabolism during early recovery from profound FDM highlights the importance of maintaining energy metabolism in myopia. The GSEA findings provide supporting evidence for the RIDE model as well as complementing earlier biometric and ultrastructural findings showing that form-deprivation occlusion leads to changes in eye volume, refraction, thinning of the retina and choroid, and morphological evidence for hyperosmolarity ([@ref-13]; [@ref-16]; [@ref-32]; [@ref-37]; [@ref-40]; [@ref-45]; [@ref-46]). Although a combination of posterior ocular tissue have been analysed in previous transcriptome studies on refractive errors ([@ref-52]; [@ref-70]; [@ref-77]; [@ref-85]; [@ref-93]), commonalities in differentially expressed genes have now been identified regardless of species, tissue analysed and genomic platform ([@ref-74]). Further studies using the GSEA approach may benefit from data collected from next-generation sequencing technologies, as transcripts are sequenced for analysis and genomic annotations are updated. Follow-up studies may also consider refining this analysis in specific retinal cell-types/tissues including the role of the vitreous in ocular development. This study provides an evidence base for further understanding of the biochemical and genetic mechanisms underlying and governing environmentally induced refractive error development in chick with implications for clinical myopia. However, there is need for greater understanding of the effects of FD recovery over a longer period of time, particularly after 72 h where greatest choroidal expansion has been reported ([Fig. 1](#fig-1){ref-type="fig"}). Future strategies to modify/supplement abnormal mitochondrial dynamics and reduce ionic induction of innate immune responses, may be an attractive therapeutic intervention target.
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###### Highly regulated biological pathways during normal eye development, form-deprivation induction and form-deprivation recovery

\(A\) Highly regulated biological pathways during normal eye development include 1 BioCarta, 17 KEGG and 43 Reactome pathways. (B) GSEA identified 1 BioCarta, 26 KEGG and 103 Reactome pathways highly regulated in response to 10 days (240 hr) of FD. (C) GSEA identified 1 Reactome pathway highy regulated in response to 24hr recovery post-occluder removal.

The tables are adjustable and information can be manipulated by cluster. Average measures for each cluster are also calculated. *ES, enrichment score; NES, normalised enrichment score; FDR, false discovery rate.*

###### 

Click here for additional data file.

10.7717/peerj.5048/supp-2

###### Pre-processing report for myopia induction and recovery microarray studies

Form-deprivation (FD) myopia induction samples are Control_6h induction (GSM151367, GSM151368, GSM151441, GSM151442, GSM151443, GSM151444), FD_6h induction (GSM151445, GSM151446, GSM151447, GSM151449, GSM151450, GSM151451), Control_72h induction (GSM151452, GSM151453, GSM151454, GSM151455, GSM151456, GSM151457) & FD_72h induction (GSM151458, GSM151459, GSM151460, GSM151461, GSM151462, GSM151463). Form-deprivation myopia recovery samples are Control (af1c11867-NL), FD 10 days (af1c1186-FD-0 hrs), 6 h recovery (af1c1160-FD-6 hrs) & 24 h recovery (af1c1160-FD-24 hrs).

###### 

Click here for additional data file.
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###### Gene information

###### 

Click here for additional data file.
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###### GSEA ranked gene list for FDMI

Pearson's correlation was used to rank and score the genes in the FDMI dataset. Genes at the top or the bottom of the ranked list of genes are highly correlated with duration of short-term occluder wear.

###### 

Click here for additional data file.
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###### Anterior chanber and lens thickness from FDMI and FDMR

Mean (±SE) measures of anterior chamber and lens thickness during normal development and following induction (FDMI) and recovery (FDMR) from form deprivation.

###### 

Click here for additional data file.
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###### Ocular Biometrics for FDMI and FDMR

Mean (±SE) measures of refractive status, axial length (AL) and vitreous chamber depth (VCD). To complement McGlinn et al (2007), refraction (A) and AL & VCD (B) were collected during 6 h and 72 h of normal development and 6h and 72 h following 7-days induction of myopia. Refraction, AL & VCD measures for 24 h recovery after prolonged form deprivation is shown in (C) and (D). Both refractive state and axial length changes were highly correlated (*r* = .78) during occluder wear (E). Note: Measures for anterior chamber and lens thickness are included in Supplementary Figure 1. Mean (±SE) measures of refractive status, axial length (AL) and vitreous chamber depth (VCD). To complement McGlinn et al (2007), refraction (A) and AL & VCD (B) were collected during 6h and 72h of normal development and 6h and 72 h following 7-days induction of myopia. Refraction, AL & VCD measures for 24 h recovery after prolonged form deprivation is shown in (C) and (D). Both refractive state and axial length changes were highly correlated (r=.78) during occluder wear (E). Note: Measures for anterior chamber and lens thickness are included in Supplementary Figure 1. \* *p* \< .05, \*\* *p* \< .01, \*\*\* *p* \< .001.

###### 

Click here for additional data file.

The Magnetic Resonance Image was courtesy of Egan, G., at the Howard Florey Neuroscience Institute.
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